ProtoKinetix Inc (PKTX)

[gosox12]

What I'm confused about:

1. Are we in such a weak bargaining position that we have to agree to non-named partners? Imagine what the share price would be if we could say we're connected to a big pharma like Phizer, Novartis, etc.

2. Does "we engaged" mean we're not getting any payments from this global multi-national for the developmental work? Who's paying for it and how much might it come to?

3. What kind of time frames are involved in all the developmental work this global multi-national will be doing for us? Are we talking a few months, or perhaps a year or more? And that's all before we can even submit to the FDA and get approval for a Phase 1 Trial.

4. What is the company's game plan? Are we aiming for partnership by a Phase 2 Trial, where a big pharma would make a significant investment in pktx; or are we planning to go it alone all the way through a Phase 3 Trial, with the company keeping 100% of the revenues? Clearly, the time frames and share price rise are vastly different under these scenarios.
Perhaps I'm mistaken here,I don't recall seeing anything from the company in the past that indicates they're looking for a big pharma partner to pay for the clinical trials

You don't have to be a basher to be asking questions about the same issues that keep appearing in the Press Releases for several years now.

Comments welcome.